+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Neurostimulation Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

  • ID: 4911450
  • Report
  • December 2019
  • Region: Global
  • 246 pages
  • Transparency Market Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • Cochlear Limited
  • EndoStim, Inc.
  • LivaNova PLC
  • Medtronic plc
  • NDI Medical
  • MORE
Neurostimulation Devices Market - Scope of the Report

the report on the global neurostimulation devices market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the market for the forecast period of 2019 to 2027. The report provides the revenue and volume of the global neurostimulation devices market for the period of 2017 - 2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global neurostimulation devices market for the forecast period.

The report has been prepared after extensive research. Primary research involved bulk of the research efforts, wherein, analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global neurostimulation devices market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of the top-down and bottom-up approach to study various phenomena in the global neurostimulation devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competitive dynamics in the global neurostimulation devices market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global neurostimulation devices market. The next section of the global neurostimulation devices report highlights the USPs, which include disease prevalence of chronic pain, Parkinson’s disease, epilepsy, and urinary incontinence, and technological advancements and new product launches.

The report also delves into the competitive landscape of the global neurostimulation devices market. Key players operating in the global neurostimulation devices treatment market have been identified, and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global neurostimulation devices treatment market report.

Key Questions Answered in Global Neurostimulation Devices Market Report
  • What is the sales/revenue and volume expected to be generated by different neurostimulation devices across all regions during the forecast period?
  • What are the key trends in the neurostimulation devices market?
  • What are the major drivers, restraints, and opportunities in the market?
  • Which region is set to expand at the fastest CAGR during the forecast period?
  • Which segment will have the highest revenue globally in 2027 and which product will expand at the fastest CAGR during the forecast period?
Global Neurostimulation Devices Market - Research Objectives and Research Approach

The comprehensive report on the global neurostimulation devices market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and health care compliances laid down by accredited agencies in the purview of research in the global neurostimulation devices market. It is followed by market introduction, market dynamics, and an overview of the global neurostimulation devices market, which includes an analysis of market drivers, restraints, and trends affecting the growth of the market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the neurostimulation devices market. The next section of the global neurostimulation devices market report highlights the USPs, including disease prevalence of Parkinson’s disease, chronic pain, urinary incontinence, and epilepsy globally, and technological advancements & new product launches in the global neurostimulation devices market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Revenue generated by and volume of key neurostimulation devices market manufacturers has been mapped to ascertain the size of the global neurostimulation devices market in terms of value and volume. The forecasts presented here assess the total revenue generated and volume of neurostimulation devices. In order to provide accurate forecasts, we initiated by sizing up the current neurostimulation devices market with the help of the parent market.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Cochlear Limited
  • EndoStim, Inc.
  • LivaNova PLC
  • Medtronic plc
  • NDI Medical
  • MORE
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Neurostimulation Devices Market

4. Market Overview
4.1. Introduction
4.2. Key Industry Developments
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Neurostimulation Devices Market Value (US$ Mn) and Volume (Units) Forecast, 2017-2027

5. Global Neurostimulation Devices Market, Key Insights
5.1. Disease Prevalence: Chronic Pain, Parkinson’s Disease, Epilepsy, Urinary Incontinence
5.2. Technological Advancements and New Product Launches

6. Global Neurostimulation Devices Market Analysis and Forecast, by Product
6.1. Introduction
6.2. Market Value (US$ Mn) and Volume (Units) Forecast, by Product, 2019-2027
6.2.1. Spinal Cord Stimulators
6.2.2. Deep Brain Stimulators
6.2.3. Cochlear Implants
6.2.4. Vagus Nerve Stimulators
6.2.5. Sacral Nerve Stimulators
6.2.6. Percutaneous Tibial Nerve Stimulators
6.2.7. Transcranial Magnetic Stimulation
6.3. Market Attractiveness Analysis, by Product

7. Global Neurostimulation Devices Market Analysis and Forecast, by Application
7.1. Introduction
7.2. Market Value (US$ Mn) Forecast, by Application, 2019-2027
7.2.1. Chronic Pain
7.2.2. Movement Disorders
7.2.3. Hearing Impairment
7.2.4. Epilepsy
7.2.5. Urinary Incontinence
7.2.6. Major Depressive Disorders
7.3. Market Attractiveness Analysis, by Application

8. Global Neurostimulation Devices Market Analysis and Forecast, by End-user
8.1. Introduction
8.2. Market Value (US$ Mn) Forecast, by End-user, 2019-2027
8.2.1. Hospitals
8.2.2. Ambulatory Surgery Centers
8.2.3. Specialty Clinics
8.3. Market Attractiveness Analysis, by End-user

9. Global Neurostimulation Devices Market Analysis and Forecast, by Region
9.1. Global Market Scenario
9.2. Market Value (US$ Mn) Forecast, by Region, 2019-2027
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region

10. North America Neurostimulation Devices Market Analysis and Forecast
10.1. Market Overview
10.2. Market Value (US$ Mn) Forecast, by Country, 2019-2027
10.2.1. U.S.
10.2.2. Canada
10.3. Market Value (US$ Mn) and Volume (Units) Forecast, by Product, 2019-2027
10.3.1. Spinal Cord Stimulators
10.3.2. Deep Brain Stimulators
10.3.3. Cochlear Implants
10.3.4. Vagus Nerve Stimulators
10.3.5. Sacral Nerve Stimulators
10.3.6. Percutaneous Tibial Nerve Stimulators
10.3.7. Transcranial Magnetic Stimulation
10.4. Market Value (US$ Mn) Forecast, by Application, 2019-2027
10.4.1. Chronic Pain
10.4.2. Movement Disorders
10.4.3. Hearing Impairment
10.4.4. Epilepsy
10.4.5. Urinary Incontinence
10.4.6. Major Depressive Disorders
10.5. Market Value (US$ Mn) Forecast, by End-user, 2019-2027
10.5.1. Hospitals
10.5.2. Ambulatory Surgery Centers
10.5.3. Specialty Clinics
10.6. Market Attractiveness Analysis
10.6.1. By Country
10.6.2. By Product
10.6.3. By Application
10.6.4. By End-user

11. Europe Neurostimulation Devices Market Analysis and Forecast
11.1. Market Overview
11.2. Market Value (US$ Mn) Forecast, by Country/Sub-region, 2019-2027
11.2.1. Germany
11.2.2. U.K.
11.2.3. France
11.2.4. Italy
11.2.5. Spain
11.2.6. Rest of Europe
11.3. Market Value (US$ Mn) and Volume (Units) Forecast, by Product, 2019-2027
11.3.1. Spinal Cord Stimulators
11.3.2. Deep Brain Stimulators
11.3.3. Cochlear Implants
11.3.4. Vagus Nerve Stimulators
11.3.5. Sacral Nerve Stimulators
11.3.6. Percutaneous Tibial Nerve Stimulators
11.3.7. Transcranial Magnetic Stimulation
11.4. Market Value (US$ Mn) Forecast, by Application, 2019-2027
11.4.1. Chronic Pain
11.4.2. Movement Disorders
11.4.3. Hearing Impairment
11.4.4. Epilepsy
11.4.5. Urinary Incontinence
11.4.6. Major Depressive Disorders
11.5. Market Value (US$ Mn) Forecast, by End-user, 2019-2027
11.5.1. Hospitals
11.5.2. Ambulatory Surgery Centers
11.5.3. Specialty Clinics
11.6. Market Attractiveness Analysis
11.6.1. By Country/Sub-region
11.6.2. By Product
11.6.3. By Application
11.6.4. By End-user

12. Asia Pacific Neurostimulation Devices Market Analysis and Forecast
12.1. Market Overview
12.2. Market Value (US$ Mn) Forecast, by Country/Sub-region, 2019-2027
12.2.1. China
12.2.2. India
12.2.3. Japan
12.2.4. Australia & New Zealand
12.2.5. Rest of Asia Pacific
12.3. Market Value (US$ Mn) and Volume (Units) Forecast, by Product, 2019-2027
12.3.1. Spinal Cord Stimulators
12.3.2. Deep Brain Stimulators
12.3.3. Cochlear Implants
12.3.4. Vagus Nerve Stimulators
12.3.5. Sacral Nerve Stimulators
12.3.6. Percutaneous Tibial Nerve Stimulators
12.3.7. Transcranial Magnetic Stimulation
12.4. Market Value (US$ Mn) Forecast, by Application, 2019-2027
12.4.1. Chronic Pain
12.4.2. Movement Disorders
12.4.3. Hearing Impairment
12.4.4. Epilepsy
12.4.5. Urinary Incontinence
12.4.6. Major Depressive Disorders
12.5. Market Value (US$ Mn) Forecast, by End-user, 2019-2027
12.5.1. Hospitals
12.5.2. Ambulatory Surgery Centers
12.5.3. Specialty Clinics
12.6. Market Attractiveness Analysis
12.6.1. By Country/Sub-region
12.6.2. By Product
12.6.3. By Application
12.6.4. By End-user

13. Latin America Neurostimulation Devices Market Analysis and Forecast
13.1. Market Overview
13.2. Market Value (US$ Mn) Forecast, by Country/Sub-region, 2019-2027
13.2.1. Brazil
13.2.2. Mexico
13.2.3. Rest of Latin America
13.3. Market Value (US$ Mn) and Volume (Units) Forecast, by Product, 2019-2027
13.3.1. Spinal Cord Stimulators
13.3.2. Deep Brain Stimulators
13.3.3. Cochlear Implants
13.3.4. Vagus Nerve Stimulators
13.3.5. Sacral Nerve Stimulators
13.3.6. Percutaneous Tibial Nerve Stimulators
13.3.7. Transcranial Magnetic Stimulation
13.4. Market Value (US$ Mn) Forecast, by Application, 2019-2027
13.4.1. Chronic Pain
13.4.2. Movement Disorders
13.4.3. Hearing Impairment
13.4.4. Epilepsy
13.4.5. Urinary Incontinence
13.4.6. Major Depressive Disorders
13.5. Market Value (US$ Mn) Forecast, by End-user, 2019-2027
13.5.1. Hospitals
13.5.2. Ambulatory Surgery Centers
13.5.3. Specialty Clinics
13.6. Market Attractiveness Analysis
13.6.1. By Country/Sub-region
13.6.2. By Product
13.6.3. By Application
13.6.4. By End-user

14. Middle East and Africa Neurostimulation Devices Market Analysis and Forecast
14.1. Market Overview
14.2. Market Value (US$ Mn) Forecast, by Country/Sub-region, 2019-2027
14.2.1. GCC Countries
14.2.2. South Africa
14.2.3. Rest of Middle East and Africa
14.3. Market Value (US$ Mn) Forecast, by Product, 2019-2027
14.3.1. Spinal Cord Stimulators
14.3.2. Deep Brain Stimulators
14.3.3. Cochlear Implants
14.3.4. Vagus Nerve Stimulators
14.3.5. Sacral Nerve Stimulators
14.3.6. Percutaneous Tibial Nerve Stimulators
14.3.7. Transcranial Magnetic Stimulation
14.4. Market Value (US$ Mn) Forecast, by Application, 2019-2027
14.4.1. Chronic Pain
14.4.2. Movement Disorders
14.4.3. Hearing Impairment
14.4.4. Epilepsy
14.4.5. Urinary Incontinence
14.4.6. Major Depressive Disorders
14.5. Market Value (US$ Mn) Forecast, by End-user, 2019-2027
14.5.1. Hospitals
14.5.2. Ambulatory Surgery Centers
14.5.3. Specialty Clinics
14.6. Market Attractiveness Analysis
14.6.1. By Country/Sub-region
14.6.2. By Product
14.6.3. By Application
14.6.4. By End-user

15. Competition Landscape
15.1. Global Neurostimulation Devices Market Share, by Company, 2018
15.2. Market Player - Competition Matrix (By Tier and Size of companies)
15.3. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
15.3.1. Boston Scientific Corporation
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Strategic Overview
15.3.2. Medtronic plc
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Abbott Laboratories
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Nevro Corp
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. LivaNova PLC
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Axonics Modulation Technologies, Inc.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Neuropace, Inc.
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. EndoStim, Inc.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. NDI Medical
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Cochlear Limited
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. Neuronetics, Inc.
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Boston Scientific Corporation
  • Medtronic plc
  • Abbott Laboratories
  • Nevro Corp
  • LivaNova PLC
  • Axonics Modulation Technologies, Inc.
  • Neuropace, Inc.
  • EndoStim, Inc.
  • NDI Medical
  • Cochlear Limited
  • Neuronetics, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll